Skip to content

Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study

Individualized Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02893072
Enrollment
600
Registered
2016-09-08
Start date
2015-11-30
Completion date
2020-12-31
Last updated
2019-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Gestational

Keywords

Diabetes, Gestational, Nutrition Therapy

Brief summary

Gestational diabetes mellitus (GDM) is one of the most frequent complications of pregnancy, that affect between 1 to 14% of population around the world. The overall purpose of this study is to determine the efficacy of individualized medical nutrition therapy (MNT) intervention to reduce and control the development of GDM.

Detailed description

The number of women with gestational diabetes mellitus had been increasing. Maternal GDM has a great impact on both the health of the mothers and the offspring. Antenatal lifestyle interventions, in particular dietary intervention appear to be feasible to improve maternal GDM and weight gain. To the best of our knowledge, there has been no such trial examining the feasibility of MNT intervention in pregnant women in Hu'nan province. The aim of this study is to evaluate the efficacy of individualized MNT intervention to reduce and control the development of GDM. This is a prospective study, 500 patients who meet inclusion and exclusion criteria will be included. The changes of glucose and weight will be evaluated every two weeks.

Interventions

The intervention group involves dietary and exercise advice and monitoring.

Sponsors

The Third Xiangya Hospital of Central South University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Women with gestational diabetes

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
intravenous glucoseevery two weeks, from date of randomization until the date of parturition, assessed up to 10 monthsInvestigators will measure the participants' intravenous glucose every two weeks.From date of randomization until the date of parturition,assessed up to 10 months.

Countries

China

Contacts

Primary ContactMin Liu, M.D.
liumin330@hotmail.com86-731-88618717
Backup ContactMeng Wang, M.M.
znxywm@163.com86-731-88618717

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026